OTCMKTS:VREOF - Vireo Health International Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Buy
Consensus Price Target: $4.00
Forecasted Upside: 90.48 %
Number of Analysts: 2
Breakdown:
0 Sell Ratings
0 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings

^$2.10 As of 05/17/2021 01:00 AM ET

▲ +0.1 (5.00%)

1 month | 3 months | 12 months

Get New Vireo Health International Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for VREOF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VREOF

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

^$4.00

▲ +90.48% Upside Potential

This price target is based on 2 analysts offering 12 month price targets for Vireo Health International in the last 3 months. The average price target is $4.00, with a high forecast of $4.00 and a low forecast of $4.00. The average price target represents a 90.48% upside from the last price of $2.10.

Buy

The current consensus among 2 polled investment analysts is to buy stock in Vireo Health International. This rating has held steady since May 2020, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

11/24/2019

0 strong buy ratings
0 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

2/22/2020

0 strong buy ratings
0 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

5/22/2020

0 strong buy ratings
1 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

8/20/2020

0 strong buy ratings
2 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

11/18/2020

0 strong buy ratings
2 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

2/16/2021

0 strong buy ratings
2 buy ratings
1 hold ratings
0 sell ratings

Ratings as of

4/17/2021

0 strong buy ratings
2 buy ratings
0 hold ratings
0 sell ratings

Ratings as of

5/17/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Details
3/26/2021	Canaccord Genuity	Reiterated Rating	Buy	$4.00	i
11/30/2020	Canaccord Genuity	Reiterated Rating	Buy	$2.00	i
9/16/2020	Craig Hallum	Initiated Coverage	Buy		i
8/27/2020	Canaccord Genuity	Reiterated Rating	Buy	$2.00	i
6/17/2020	Canaccord Genuity	Lower Price Target	Buy	$2.00 ➝ $1.75	i
5/15/2020	Eight Capital	Downgrade	Buy ➝ Neutral	$0.65	i

(Data available from 5/18/2016 forward)

Vireo Health International Inc. operates as a physician-led cannabis company in the United States. It cultivates cannabis; manufactures pharmaceutical-grade cannabis extracts; and sells its products through its network of Green Goods and other retail locations, and third-party dispensaries. The company grows and/or processes cannabis in eight markets and operates 16 dispensaries. Vireo Health International Inc. is headquartered in Minneapolis, Minnesota.

Today's Range

Now: $2.10

$2.01

$2.12

50 Day Range

MA: $2.17

$1.83

$2.45

52 Week Range

Now: $2.10

$0.45

$3.84

Volume

98,277 shs

Average Volume

420,654 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Vireo Health International?

The following sell-side analysts have issued research reports on Vireo Health International in the last year: Canaccord Genuity, and Craig Hallum.
View the latest analyst ratings for VREOF.

What is the current price target for Vireo Health International?

1 Wall Street analysts have set twelve-month price targets for Vireo Health International in the last year. Their average twelve-month price target is $4.00, suggesting a possible upside of 90.5%. Canaccord Genuity has the highest price target set, predicting VREOF will reach $4.00 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of $4.00 for Vireo Health International in the next year.
View the latest price targets for VREOF.

What is the current consensus analyst rating for Vireo Health International?

Vireo Health International currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VREOF will outperform the market and that investors should add to their positions of Vireo Health International.
View the latest ratings for VREOF.

What other companies compete with Vireo Health International?

Other companies that are similar to Vireo Health International include (CSI), 1933 Industries, 28896, 4Front Ventures, AB Science, Abattis Bioceuticals, Acreage, Acreage, AFT Pharmaceuticals, Agraflora Organics International, AgraFlora Organics International, Aleafia Health, American Green, Australian Primary Hemp and Ayr Wellness.

How do I contact Vireo Health International's investor relations team?

The company's listed phone number is 612-314-8995. The official website for Vireo Health International is www.vireohealth.com.